Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

Combining anlotinib with STUPP regimen improves survival in glioblastoma patients

Combining anlotinib with STUPP regimen improves survival in glioblastoma patients

Existing drug alleviates symptoms of a rare genetic syndrome

Existing drug alleviates symptoms of a rare genetic syndrome

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

Combination therapy offers breakthrough in NSCLC treatment

Combination therapy offers breakthrough in NSCLC treatment

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

Glioblastoma tumor cells mimic neurons to evade treatment

Glioblastoma tumor cells mimic neurons to evade treatment

Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis

Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Unraveling the role of HER2 mutant alleles in breast cancer

Unraveling the role of HER2 mutant alleles in breast cancer

Using ripretinib and surgery to manage recurrent gastrointestinal stromal tumor

Using ripretinib and surgery to manage recurrent gastrointestinal stromal tumor

New treatment breakthrough: Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

New treatment breakthrough: Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Parkinson's disease diagnosis could be made earlier with new blood test

Parkinson's disease diagnosis could be made earlier with new blood test

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

New method can kill aggressive brain tumors

New method can kill aggressive brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.